Physician_Profile_ID,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Form_of_Payment_or_Transfer_of_Value,Record_ID,Name_of_Associated_Covered_Drug_or_Biological1,Name_of_Associated_Covered_Drug_or_Biological2,Name_of_Study,Research_Information_Link,Context_of_Research
538515,"ELI LILLY AND COMPANY",IN,100000000088,1175.00,01/01/2014,"In-kind items and services",144081846,"","","ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE -A4 STUDY",http://clinicaltrials.gov/ct2/show/NCT02008357,"THE AMOUNT REPORTED REPRESENTS EITHER AN AGGREGATE OF CASH PAYMENTS -E.G. CLINICAL STUDY SERVICES, REIMBURSEMENTS FOR EXPENSES OR PASS-THROUGH COSTS- OR AN AGGREGATE OF IN-KIND VALUE -E.G. SUPPLIES, EQUIPMENT- PROVIDED BY LILLY OR BY A THIRD PARTY VENDOR IN CONNECTION WITH CLINICAL STUDIES DURING THE REPORTING PERIOD.  FOR AVAILABLE STUDY DETAILS, PLEASE VISIT CLINICALTRIALS.GOV."
